Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Stocktreeon Nov 23, 2023 3:19pm
193 Views
Post# 35750509

The pumpsicles keep pumping with zero content.

The pumpsicles keep pumping with zero content.
Any post here aside from MM's, Accuntpice's and their shadows has more value than their incessant pumps/ads for their stock.

Promoting that we are near 90% to a target of 90/150 patient mark, without mentioning the 150 target is just baloney and any post encouraging it is baloney as well.

All critics coming from the above gang of sleazy posters are almost always direct projection. They claim other posters are profitting from the 28-40-28 SP ondulation, while they are the ones always happy to announce they buy low and sell high. In the meantime, the 90 mark campaign has now lost a lot of its punch and they will gradually push back their target as we see the pace of enrolment not answer to their promises (by end of year, end of january, end of february). And remember the "flu season" argument pushed here in the fall of 2022? Still at it recently. It did nothing back then and will do nothing again. The trial heads will even probably reject any covid/flu stricken patient anyway. Any money invested in this right now is just asking to be diluted over the next year or two years, or three years.

Then, if the trial is ever successful, the company will probably be privatized before any substantial gain is made with long stocks.
<< Previous
Bullboard Posts
Next >>